# A Study of Bomedemstat (MK-3543) in Participants With Mild or Moderate Hepatic Impairment (MK-3543-023)

> **NCT07049939** · PHASE1 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 9 (actual)

## Conditions studied

- Hepatic Insufficiency

## Interventions

- **DRUG:** Bomedemstat

## Key facts

- **NCT ID:** NCT07049939
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-08-20
- **Primary completion:** 2026-02-17
- **Final completion:** 2026-02-17
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2026-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07049939

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07049939, "A Study of Bomedemstat (MK-3543) in Participants With Mild or Moderate Hepatic Impairment (MK-3543-023)". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT07049939. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*